You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 291 No. 22, June 9, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (39)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Oncology
 •Ovarian Cancer
 •Women's Health, Other
 •Diagnosis
 •Alert me on articles by topic

Frequency of Symptoms of Ovarian Cancer in Women Presenting to Primary Care Clinics

Barbara A. Goff, MD; Lynn S. Mandel, PhD; Cindy H. Melancon, RN; Howard G. Muntz, MD

JAMA. 2004;291:2705-2712.

Context  Women with ovarian cancer frequently report symptoms prior to diagnosis, but distinguishing these symptoms from those that normally occur in women remains problematic.

Objective  To compare the frequency, severity, and duration of symptoms between women with ovarian cancer and women presenting to primary care clinics.

Design, Setting, and Patients  A prospective case-control study of women who visited 2 primary care clinics (N = 1709) and completed an anonymous survey of symptoms experienced over the past year (July 2001-January 2002). Severity of symptoms was rated on a 5-point scale, duration was recorded, and frequency was indicated as number of episodes per month. An identical survey was administered preoperatively to 128 women with a pelvic mass (84 benign and 44 malignant).

Main Outcome Measures  Comparison of self-reported symptoms between ovarian cancer patients and women seeking care in primary care clinics.

Results  In the clinic population, 72% of women had recurring symptoms with a median number of 2 symptoms. The most common were back pain (45%), fatigue (34%), bloating (27%), constipation (24%), abdominal pain (22%), and urinary symptoms (16%). Comparing ovarian cancer cases to clinic controls resulted in an odds ratio of 7.4 (95% confidence interval [CI], 3.8-14.2) for increased abdominal size; 3.6 (95% CI, 1.8-7.0) for bloating; 2.5 (95% CI, 1.3-4.8) for urinary urgency; and 2.2 (95% CI, 1.2-3.9) for pelvic pain. Women with malignant masses typically experienced symptoms 20 to 30 times per month and had significantly more symptoms of higher severity and more recent onset than women with benign masses or controls. The combination of bloating, increased abdominal size, and urinary symptoms was found in 43% of those with cancer but in only 8% of those presenting to primary care clinics.

Conclusions  Symptoms that are more severe or frequent than expected and of recent onset warrant further diagnostic investigation because they are more likely to be associated with both benign and malignant ovarian masses.


Author Affiliations: Department of Obstetrics and Gynecology, University of Washington School of Medicine, Seattle (Drs Goff and Mandel); Conversations, Amarillo, Tex (Ms Melancon); and Virginia Mason Medical Center, Seattle, Wash (Dr Muntz). Dr Melancon is deceased.


RELATED ARTICLE

Symptoms of Ovarian Cancer—Where to Set the Bar?
Mary B. Daly and Robert F. Ozols
JAMA. 2004;291(22):2755-2756.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A terrible beauty: A physician's story of ovarian cancer
Spano
cfp 2007;53:983-985.
FULL TEXT  

Symptoms, Diagnoses, and Time to Key Diagnostic Procedures Among Older U.S. Women With Ovarian Cancer
Ryerson et al.
Obstet Gynecol 2007;109:1053-1061.
ABSTRACT | FULL TEXT  

Minimizing delays in ovarian cancer diagnosis: an expansion of Andersen's model of 'total patient delay'
Evans et al.
Fam Pract 2007;24:48-55.
ABSTRACT | FULL TEXT  

Characterization of Ovarian Surface Epithelial Cells from the Hen: A Unique Model for Ovarian Cancer
Giles et al.
Exp. Biol. Med. 2006;231:1718-1725.
ABSTRACT | FULL TEXT  

Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.
Lacey et al.
JNCI J Natl Cancer Inst 2006;98:1397-1405.
ABSTRACT | FULL TEXT  

Case 11-2006 -- A 54-Year-Old Woman with a Mass in the Pelvis
Krasner et al.
NEJM 2006;354:1615-1625.
FULL TEXT  

Update in Women's Health
Crandall and Pregler
ANN INTERN MED 2005;143:823-829.
FULL TEXT  

Early symptoms of ovarian cancer: a case-control study without recall bias
Friedman et al.
Fam Pract 2005;22:548-553.
ABSTRACT | FULL TEXT  

Fruits and Vegetables and Ovarian Cancer Risk in a Pooled Analysis of 12 Cohort Studies
Koushik et al.
Cancer Epidemiol. Biomarkers Prev. 2005;14:2160-2167.
ABSTRACT | FULL TEXT  

Is late diagnosis of lung cancer inevitable? Interview study of patients' recollections of symptoms before diagnosis
Corner et al.
Thorax 2005;60:314-319.
ABSTRACT | FULL TEXT  

Ovarian Malignancy in Breast Cancer Patients With an Adnexal Mass
Simpkins et al.
Obstet Gynecol 2005;105:507-513.
ABSTRACT | FULL TEXT  

Ovarian Cancer Is Not So Silent
JWatch Women's Health 2004;2004:3-3.
FULL TEXT  

Symptoms Associated with Ovarian Cancer
JWatch General 2004;2004:4-4.
FULL TEXT  

Symptoms of Ovarian Cancer--Where to Set the Bar?
Daly and Ozols
JAMA 2004;291:2755-2756.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.